| # | Drug | Count |
|---|---|---|
| 0 | METFORMIN | 156 |
| 1 | METFORMIN ER 500 MG | 134 |
| 2 | METFORMIN ER 750 MG | 134 |
| 3 | EMPAGLIFLOZIN | 121 |
| 4 | OLANZAPINE | 90 |
| 5 | OLANZAPINE PAMOATE | 75 |
| 6 | DAPAGLIFLOZIN | 63 |
| 7 | INSULIN GLARGINE | 57 |
| 8 | CANAGLIFLOZIN | 41 |
| 9 | INSULIN | 39 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FLUPHENAZINE HYDROCHLORIDE | 2 | 0.0174 |
| 1 | BENZGALANTAMINE | 1 | 0.0122 |
| 2 | CROVALIMAB | 1 | 0.0083 |
| 3 | DARIFENACIN HYDROBROMIDE | 6 | 0.0069 |
| 4 | EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 14 | 0.0047 |
| 5 | FLUPHENAZINE DECANOATE | 2 | 0.0046 |
| 6 | CAFFEINE, MAGNESIUM SALICYLATE | 1 | 0.0039 |
| 7 | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | 14 | 0.0039 |
| 8 | ERYTHROMYCIN ETHYLSUCCINATE | 2 | 0.0032 |
| 9 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 10 | 0.0029 |
| # | Drug class | Count |
|---|---|---|
| 0 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 189 |
| 1 | Insulin Analog [EPC] | 131 |
| 2 | Atypical Antipsychotic [EPC] | 115 |
| 3 | Corticosteroid [EPC] | 60 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 57 |
| 5 | Benzodiazepine [EPC] | 45 |
| 6 | GLP-1 Receptor Agonist [EPC] | 36 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 29 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 28 |
| 9 | Proton Pump Inhibitor [EPC] | 24 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Complement C5 Inhibitor [EPC] | 1 | 0.0083 |
| 1 | Carbamoyl Phosphate Synthetase 1 Activator [EPC] | 2 | 0.0027 |
| 2 | Tricyclic Antidepressant [EPC] | 1 | 0.0021 |
| 3 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 189 | 0.0017 |
| 4 | Leptin Analog [EPC] | 2 | 0.0016 |
| 5 | Type I Interferon Receptor Antagonist [EPC] | 3 | 0.0016 |
| 6 | CD3-directed Antibody [EPC] | 1 | 0.0014 |
| 7 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 20 | 0.0006 |
| 8 | Carnitine Analog [EPC] | 2 | 0.0005 |
| 9 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 2 | 0.0005 |